Selection bias in clinical trials of anaplastic glioma
- PMID: 2684003
- DOI: 10.1002/ana.410260406
Selection bias in clinical trials of anaplastic glioma
Abstract
We report a retrospective analysis of survival, and attrition to a study, of patients with anaplastic glioma seen at a regional cancer center during its participation in a prospective randomized clinical trial. Median length of survival for all patients was 35 weeks. Median length of survival for study patients was 60 weeks. Study patients were not representative of all patients; they were younger and less disabled than the nonstudy patients. Survival predictions for patients with anaplastic glioma based on the results of clinical trials may be overly optimistic. Many trials study a nonrepresentative subset of patients with anaplastic glioma, excluding those who do poorly at the outset and those who have poor function.
Similar articles
-
Radiotherapy management of patients diagnosed with glioma in Victoria (1998-2000): a retrospective cohort study.J Med Imaging Radiat Oncol. 2009 Jun;53(3):318-24. doi: 10.1111/j.1754-9485.2009.02072.x. J Med Imaging Radiat Oncol. 2009. PMID: 19624300
-
Retrospective analysis of re-irradiation in malignant glioma: a single-center experience.Wien Klin Wochenschr. 2005 Dec;117(23-24):821-6. doi: 10.1007/s00508-005-0475-z. Wien Klin Wochenschr. 2005. PMID: 16437319
-
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):47-55. doi: 10.1016/j.ijrobp.2005.05.024. Int J Radiat Oncol Biol Phys. 2005. PMID: 16111571 Review.
-
Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.Strahlenther Onkol. 1995 Jun;171(6):315-21. Strahlenther Onkol. 1995. PMID: 7597616
-
Gliomatosis cerebri: treatment results with radiotherapy alone.Cancer. 2002 Nov 1;95(9):2027-31. doi: 10.1002/cncr.10909. Cancer. 2002. PMID: 12404298 Review.
Cited by
-
Comparison of survival outcomes among cancer patients treated in and out of clinical trials.J Natl Cancer Inst. 2014 Mar;106(3):dju002. doi: 10.1093/jnci/dju002. Epub 2014 Mar 13. J Natl Cancer Inst. 2014. PMID: 24627276 Free PMC article.
-
The role of cytoreductive surgery in multifocal/multicentric glioblastomas.J Neurooncol. 2023 Sep;164(2):447-459. doi: 10.1007/s11060-023-04410-7. Epub 2023 Sep 12. J Neurooncol. 2023. PMID: 37697210 Free PMC article.
-
Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.Radiat Oncol. 2009 Nov 23;4:57. doi: 10.1186/1748-717X-4-57. Radiat Oncol. 2009. PMID: 19930657 Free PMC article. Clinical Trial.
-
Brain tumor survival: results from the National Cancer Data Base.J Neurooncol. 1998 Nov;40(2):151-60. doi: 10.1023/a:1006091608586. J Neurooncol. 1998. PMID: 9892097
-
Modeling Adult Gliomas Using RCAS/t-va Technology.Transl Oncol. 2009 May;2(2):89-95. doi: 10.1593/tlo.09100. Transl Oncol. 2009. PMID: 19412424 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical